Mara R. Jonasson Email & Phone Number

Westlake Village, Ca, Us

Cambridge, Ma, Us

• Evaluate payer contract strategies to inform Pricing Committee recommendations, partner with National Account Directors to negotiate contract offers, draft/redline contract language, provide projections for Finance Latest Estimates (LE). Lead GP policy reviews with Finance, Legal, outside counsel, and GP vendors.• TA: Rare Disease - Duchenne Muscular Dystrophy (DMD)• Product Launch: Elevidys Gene Therapy• Created financial model to assess GP (DRM, AMP, BP, Multiple BP) and GTN impacts of commercial contracting strategies for gene therapy. Scope of assessments includes value-based arrangements and warranty offerings. • Developed rules-based approach for determining differential rebates in states where Medicaid managed care organizations have control over drug policy and/or carry the financial risk for the product. • Led comprehensive review of GP reasonable assumptions documentation and drafted substantive updates to GP policies to account for Sarepta’s evolving business practices.

• Oversaw renovations of personal residence and planned micro-wedding in Scotland.

Burlington, Massachusetts, Us

• Model impacts (ASP, GTN) of provider contract strategies and create recommendations for Pricing Committee. Draft/redline contract language, oversee execution of rebates, fee payments, and contract pricing/chargebacks. Advise Finance, Legal, and vendor on GP matters. • TA: Osteoarthritis• Led successful implementation of commercial off-invoice discount pricing with Trade, Commercial Operations, Finance, 3PLs, and specialty distributors.

San Mateo, California, Us

• Accountable for designing government pricing system enhancements for GP, DRM, and FSS modules. Collaborate with Top 25 biopharma manufacturers to implement flexible solutions that support compliance and industry business practices. Analyze value-based contracts offered by Model N customers to inform new DRM features. Draft comment letters for proposed drug pricing legislation.• Utilized deep domain expertise to devise new discount reallocation functionality that did not require revision following significant mid-project requirement changes by two Top 5 biopharma companies.

Toronto, On, Ca

• Author GP policy, methodology, and reasonable assumptions documents. Conduct compliance assessments and conference presentations. Manage engagements, furnish client deliverables, direct project staff. • Assisted biotech and pharmaceutical companies with remediation of Corporate Integrity Agreements.

Foster City, Ca, Us

• Analyze impact of business decisions and regulatory changes on Gilead’s pricing policies. Manage GP team, ensure government pricing and contracting compliance, oversee class of trade assignments, review the accuracy of 340B and FSS transactions, execute product launch efforts, monitor budgets, maintain accruals, and advise on cross-functional projects. • TAs: HIV/AIDS, Liver Disease, Hematology/Oncology, Cardiovascular, Inflammation/Respiratory• Product Launches: Descovy®, Genvoya®, Odefsey®• Partnered with Legal to interpret and implement the provisions of the Affordable Care Act (ACA).• Assured business continuity by training two or more resources for each GP task.

Thousand Oaks, Ca, Us

• Assess impact of business decisions and regulatory changes on Amgen’s pricing policies and GTN. Manage staff, perform robust data validations, verify system-generated government prices through objective calculation models, present results to executive leadership, author documents, execute product launch efforts, maintain accruals, and advise on cross-functional projects. • TAs: Oncology, Bone Health, Nephrology, Inflammation• Product Launches: Vectibix®, Nplate®, Prolia®, XGEVA®• Partnered with Legal to interpret and implement the provisions of the Deficit Reduction Act (DRA).• Outlined discount reallocation requirements and created results verification models.• Developed Risks and Control Matrix to mitigate risks to government price reporting. Led the creation of a GP sub-certification process to ensure execution of related controls. • Defined a new class of trade (COT) schema to support business operations.• Functional area lead for Model N system implementation. Influenced Model N to enhance base product and identified sustainable workarounds to address functional gaps.• Functional area lead for SAP system implementation. • Developed tools to quickly identify the source of GP variances (current vs. prior, actual vs. forecast).• Established process to reconcile Government Pricing System data to the general ledger and source systems.

Master Of Business Administration (Mba)

Certificate, Global Enterprise Management

Bachelor Of Science (Bs), Accounting